These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36688047)
1. Ligand and structure-based approaches for the exploration of structure-activity relationships of fusidic acid derivatives as antibacterial agents. Zheng W; Tu B; Zhang Z; Li J; Yan Z; Su K; Deng D; Sun Y; Wang X; Zhang B; Zhang K; Wong WL; Wu P; Hong WD; Ang S Front Chem; 2022; 10():1094841. PubMed ID: 36688047 [No Abstract] [Full Text] [Related]
2. Synthesis and Biological Evaluation of Novel Fusidic Acid Derivatives as Two-in-One Agent with Potent Antibacterial and Anti-Inflammatory Activity. Tu B; Cao N; Zhang B; Zheng W; Li J; Tang X; Su K; Li J; Zhang Z; Yan Z; Li D; Zheng X; Zhang K; Hong WD; Wu P Antibiotics (Basel); 2022 Jul; 11(8):. PubMed ID: 36009895 [TBL] [Abstract][Full Text] [Related]
3. Methylene blue analogues: In vitro antimicrobial minimum inhibitory concentrations and in silico pharmacophore modelling. Thesnaar L; Bezuidenhout JJ; Petzer A; Petzer JP; Cloete TT Eur J Pharm Sci; 2021 Feb; 157():105603. PubMed ID: 33091571 [TBL] [Abstract][Full Text] [Related]
5. Integration of multiscale molecular modeling approaches with the design and discovery of fusidic acid derivatives. Lu J; Ni JX; Wang JA; Liu ZY; Shang KL; Bi Y Future Med Chem; 2019 Jun; 11(12):1427-1442. PubMed ID: 31304828 [No Abstract] [Full Text] [Related]
7. Bioactivities and Structure-Activity Relationships of Fusidic Acid Derivatives: A Review. Long J; Ji W; Zhang D; Zhu Y; Bi Y Front Pharmacol; 2021; 12():759220. PubMed ID: 34721042 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of Fusidic Acid Derivatives Yields a Potent Antibiotic with an Improved Resistance Profile. Garcia Chavez M; Garcia A; Lee HY; Lau GW; Parker EN; Komnick KE; Hergenrother PJ ACS Infect Dis; 2021 Feb; 7(2):493-505. PubMed ID: 33522241 [TBL] [Abstract][Full Text] [Related]
9. The biological evaluation of fusidic acid and its hydrogenation derivative as antimicrobial and anti-inflammatory agents. Wu PP; He H; Hong WD; Wu TR; Huang GY; Zhong YY; Tu BR; Gao M; Zhou J; Zhao SQ; Li DL; Xu XT; Sheng ZJ; Ward SA; O'Neill PM; Zhang K Infect Drug Resist; 2018; 11():1945-1957. PubMed ID: 30498366 [TBL] [Abstract][Full Text] [Related]
10. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors. Tripathy S; Azam MA; Jupudi S; Sahu SK J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860 [TBL] [Abstract][Full Text] [Related]
11. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators. Gajjar KA; Gajjar AK Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214 [TBL] [Abstract][Full Text] [Related]
12. Pharmacophore modeling and 3D-QSAR study for the design of novel α-synuclein aggregation inhibitors. Yang J; Hu J; Zhang G; Qin L; Wen H; Tang Y J Mol Model; 2021 Aug; 27(9):260. PubMed ID: 34432157 [TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR Modeling and Synthesis of New Fusidic Acid Derivatives as Antiplasmodial Agents. Kaur G; Pavadai E; Wittlin S; Chibale K J Chem Inf Model; 2018 Aug; 58(8):1553-1560. PubMed ID: 30040885 [TBL] [Abstract][Full Text] [Related]
14. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4. Gaurav A; Singh R Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, Characterization, Antibacterial and Antioxidant Potency of NSubstituted- 2-Sulfanylidene-1,3-Thiazolidin-4-one Derivatives and QSAR Study. Brahmbhatt H; Molnar M; Pavić V; Rastija V Med Chem; 2019; 15(8):840-849. PubMed ID: 30520381 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, antifungal activity and potential mechanism of fusidic acid derivatives possessing amino-terminal groups. Cao Y; Ni J; Ji W; Shang K; Liang K; Lu J; Bi Y; Luo X Future Med Chem; 2020 May; 12(9):763-774. PubMed ID: 32208979 [No Abstract] [Full Text] [Related]
17. Generation of pharmacophore and atom based 3D-QSAR model of novel isoquinolin-1-one and quinazolin-4-one-type inhibitors of TNFα. Hanumanthappa P; Teli MK; Krishnamurthy RG Med Chem; 2012 May; 8(3):436-51. PubMed ID: 22530913 [TBL] [Abstract][Full Text] [Related]
18. Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs. Gao J; Liang L; Zhu Y; Qiu S; Wang T; Zhang L Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428963 [TBL] [Abstract][Full Text] [Related]
19. Vaghefinezhad N; Farsani SF; Gharaghani S Curr Drug Discov Technol; 2021; 18(1):139-157. PubMed ID: 31721705 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship analyses of fusidic acid derivatives highlight crucial role of the C-21 carboxylic acid moiety to its anti-mycobacterial activity. Singh K; Kaur G; Shanika PS; Dziwornu GA; Okombo J; Chibale K Bioorg Med Chem; 2020 Jul; 28(13):115530. PubMed ID: 32362386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]